(NASDAQ: PSNL) Personalis's forecast annual revenue growth rate of 22.09% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 7.32%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.92%.
Personalis's revenue in 2024 is $73,481,000.On average, 3 Wall Street analysts forecast PSNL's revenue for 2024 to be $3,735,974,685, with the lowest PSNL revenue forecast at $3,726,681,969, and the highest PSNL revenue forecast at $3,743,954,299. On average, 3 Wall Street analysts forecast PSNL's revenue for 2025 to be $4,373,636,787, with the lowest PSNL revenue forecast at $3,873,648,286, and the highest PSNL revenue forecast at $4,975,643,144.
In 2026, PSNL is forecast to generate $7,276,044,784 in revenue, with the lowest revenue forecast at $5,456,339,160 and the highest revenue forecast at $9,095,750,409.